Efficacy of INM004 in Children With STEC-HUS

Clinical trial NCT06389474 · RECRUITING

Trial details

NCT number: NCT06389474
Sponsor: Inmunova S.A.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hemolytic-Uremic Syndrome

Start date: 2024-10-05
Primary completion: 2026-08-30
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.